Serina Therapeutics Inc计划在2025年第四季度提交美国IND申请,预计将于2026年第一季度开始在美国进行患者入组。
Serina Therapeutics Inc计划在2025年第四季度提交美国IND申请,预计将于2026年第一季度开始在美国进行患者入组。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.